Cholangiocarcinoma 2020: the next horizon in mechanisms and management

JM Banales, JJG Marin, A Lamarca… - Nature reviews …, 2020 - nature.com
Cholangiocarcinoma (CCA) includes a cluster of highly heterogeneous biliary malignant
tumours that can arise at any point of the biliary tree. Their incidence is increasing globally …

[HTML][HTML] WNT/β-catenin signaling in the development of liver cancers

S He, S Tang - Biomedicine & pharmacotherapy, 2020 - Elsevier
The WNT/β-catenin signaling pathway is a highly conserved and tightly controlled molecular
mechanism that regulates embryonic development, cellular proliferation and differentiation …

Cholangiocyte pathobiology

JM Banales, RC Huebert, T Karlsen… - Nature Reviews …, 2019 - nature.com
Cholangiocytes, the epithelial cells lining the intrahepatic and extrahepatic bile ducts, are
highly specialized cells residing in a complex anatomic niche where they participate in bile …

Wnt–β-catenin signalling in liver development, health and disease

MJ Perugorria, P Olaizola, I Labiano… - Nature reviews …, 2019 - nature.com
The canonical Wnt–β-catenin pathway is a complex, evolutionarily conserved signalling
mechanism that regulates fundamental physiological and pathological processes. Wnt–β …

Pathogenesis of cholangiocarcinoma

PM Rodrigues, P Olaizola, NA Paiva… - Annual Review of …, 2021 - annualreviews.org
Cholangiocarcinoma (CCA) encompasses a group of malignancies that can arise at any
point in the biliary tree. Although considered a rare cancer, the incidence of CCA is …

Wnt/β-catenin signaling in liver cancers

W Wang, R Smits, H Hao, C He - Cancers, 2019 - mdpi.com
Liver cancer is among the leading global healthcare issues associated with high morbidity
and mortality. Liver cancer consists of hepatocellular carcinoma (HCC), cholangiocarcinoma …

Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions

RIR Macias, V Cardinale, TJ Kendall, MA Avila… - Gut, 2022 - gut.bmj.com
Cholangiocarcinoma (CCA) is a malignant tumour arising from the biliary system. In Europe,
this tumour frequently presents as a sporadic cancer in patients without defined risk factors …

Evolution of the experimental models of cholangiocarcinoma

A Massa, C Varamo, F Vita, S Tavolari, C Peraldo-Neia… - Cancers, 2020 - mdpi.com
Cholangiocarcinoma (CCA) is a rare, aggressive disease with poor overall survival. In
advanced cases, surgery is often not possible or fails; in addition, there is a lack of effective …

Diagnostic and prognostic biomarkers in cholangiocarcinoma

RIR Macias, M Kornek, PM Rodrigues… - Liver …, 2019 - Wiley Online Library
The high mortality rate of cholangiocarcinoma (CCA) is due, in part, to the lack of non‐
invasive approaches able to accurately detect this silent tumour at early stages, when …

Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

DF Calvisi, L Boulter, J Vaquero… - Nature Reviews …, 2023 - nature.com
Cholangiocarcinoma (CCA) is a rare malignancy that develops at any point along the biliary
tree. CCA has a poor prognosis, its clinical management remains challenging, and effective …